HOME Top Market Reports Digital Pathology Market by Product (Scanners, Software), Type (Human, Animal Pathology), End User (Pharmaceutical Company, Hospital, Academic Institutions), Application (Teleconsultation, Drug Discovery) - Global Forecasts to 2021

Digital Pathology Market by Product (Scanners, Software), Type (Human, Animal Pathology), End User (Pharmaceutical Company, Hospital, Academic Institutions), Application (Teleconsultation, Drug Discovery) - Global Forecasts to 2021

By: marketsandmarkets.com
Publishing Date: May 2016
Report Code: HIT 2608

Discount on Reports  

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


Digital pathology is an image-based information environment that allows for the management of information generated from a digital slide. A digital slide image file is then generated, which allows for high-resolution viewing. The global digital pathology market is expected to reach USD 679.1 Million in 2021, growing at a CAGR of 12.1% during the forecast period. Rising prevalence of cancer; increasing tele-consultations; utilization of digital pathology for drug discovery, biomarkers, and companion diagnostics; growing number of studies on digital pathology; and improvements in laboratory workflow efficiency are driving the demand for digital pathology systems and solutions.

Objectives of the Study

  • To define, describe, and forecast the global digital pathology market on the basis of product, type, application, end user, and region
  • To provide detailed information regarding major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the digital pathology market with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World
  • To strategically profile the key players in the global digital pathology market and comprehensively analyze their core competencies
  • To track and analyze competitive developments such as joint ventures and alliances, mergers and acquisitions, new product/technology development, and research and development activities of the leading players in the global digital pathology market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global digital pathology market and estimate the size of various other dependent submarkets. Various secondary sources such as directories, industry journals, databases such as Hoover’s, Bloomberg Business, Factiva, and Avention, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

Digital Pathology Market

To know about the assumptions considered for the study, download the pdf brochure

Some prominent players in the global digital pathology market are Leica Biosystems Nussloch GMBH (Germany), Ventana Medical Systems, Inc. (U.S.), Hamamatsu Photonics K.K (Japan), 3DHISTECH Ltd. (Hungary), Philips Healthcare (Netherlands), Apollo Enterprise Imaging Corp. (U.S.), XIFIN, Inc. (U.S.), Definiens AG (Germany), Visiopharm A/S (Denmark), Omnyx, LLC (U.S.), and Corista LLC (U.S.).

Target Audience:

  • Digital pathology Kits & Devices Manufacturers and Distributors
  • Healthcare Institutions (Hospitals, Laboratories, Medical Schools, and Outpatient Clinics)
  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
  • Government Associations
  • Market Research and Consulting Firms
  • Venture Capitalists and Investors

Scope of the Report

The research report categorizes the global digital pathology market into the following segments and subsegments:

Global Digital pathology Market, by Product

  • Scanners
  • Software
  • Communication Systems
  • Storage Systems

Global Digital pathology Market, by Type

  • Human Digital Pathology
  • Animal Digital Pathology

Global Digital pathology Market, by Application

  • Disease
  • Teleconsultation
  • Drug Discovery
  • Training and Education

Global Digital pathology Market, by End User

  • Pharmaceutical & Biotechnology Companies and CROs
  • Hospitals and Reference Laboratories
  • Academic & Government Research Institutes

Global Digital pathology Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • EU - 5
    • Rest of Europe (RoE)
  • Asia-pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Company Information

  • Detailed analysis and profiling of additional market players (up to 3)

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 17)
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
           2.2.2 Primary Research
                    2.2.2.1 Key Data From Primary Sources
                    2.2.2.2 Key Insights From Primary Sources
                    2.2.2.3 Key Industry Insights
    2.3 Market Size Estimation Methodology
    2.4 Research Design
    2.5 Market Data Validation and Triangulation
    2.6 Assumptions for the Study

3 Executive Summary (Page No. - 26)
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights (Page No. - 31)
    4.1 Overview of the Market
    4.2 Geographic Analysis of the Market
    4.3 Market, By Type
    4.4 Market, By End User
    4.5 Market, By Application
    4.6 Geographic Snapshot of the Market

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Rising Prevalence of Cancer
                    5.3.1.2 Increasing Adoption of Digital Pathology to Enhance Lab Efficiency
                    5.3.1.3 Growing Application of Digital Pathology in Drug Development and Companion Diagnostics
                    5.3.1.4 Ease of Consultation Enabled By Digital Pathology
                    5.3.1.5 Increasing Initiatives By Governments and Industry Players
                    5.3.1.6 Increasing Number of Research Projects Establishing the Efficacy of Digital Pathology
           5.3.2 Restraints
                    5.3.2.1 High Cost of Digital Pathology Systems
                    5.3.2.2 Regulatory Concerns
                    5.3.2.3 Lack of Standard Guidelines
                    5.3.2.4 Reluctance Among Pathologists to Adopt Advanced Technologies
           5.3.3 Opportunities
                    5.3.3.1 Digital Pathology to Help Combat the Shortage of Pathologists
                    5.3.3.2 Introduction of Affordable Scanners for Private Pathology Practices
                    5.3.3.3 Personalized Medicine to Open Array of Opportunities
                    5.3.3.4 Integration of Laboratory Information Systems (LIS) and Digital Pathology Systems
                    5.3.3.5 Increasing Digital Pathology Initiatives in Asia
    5.4 Regulatory Implications
           5.4.1 Health Insurance Portability and Accountability Act (HIPAA)
           5.4.2 Food and Drug Administration (FDA)
           5.4.3 Clinical Laboratory Improvement Amendments (CLIA)

6 Digital Pathology Market, By Product (Page No. - 44)
    6.1 Introduction
    6.2 Scanners
    6.3 Software
    6.4 Communication Systems
    6.5 Storage Systems

7 Digital Pathology Market, By Type (Page No. - 51)
    7.1 Introduction
    7.2 Human Digital Pathology
    7.3 Animal Digital Pathology

8 Digital Pathology Market, By End User (Page No. - 55)
    8.1 Introduction
    8.2 Pharmaceutical & Biotechnology Companies and Cro’s
    8.3 Hospitals and Reference Laboratories
    8.4 Academic & Government Research Institutes

9 Digital Pathology Market, By Application (Page No. - 60)
    9.1 Introduction
    9.2 Teleconsultation
    9.3 Disease Diagnosis
    9.4 Drug Discovery
    9.5 Training and Education

10 Global Digital Pathology Market, By Region (Page No. - 66)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
                        10.2.1.1 Favorable Reimbursement Scenario for Digital Pathology in the U.S.
                        10.2.1.2 Rising Cancer Prevalence in the U.S.
                        10.2.1.3 De Novo Application By the FDA
             10.2.2 Canada
                        10.2.2.1 Growing Need for Quality Cancer Diagnosis in Canada
                        10.2.2.2 Implementation of Favorable Initiatives By Canadian Authorities
     10.3 Europe
             10.3.1 EU-5
                        10.3.1.1 Initiatives Adopted By Nhs England Promoting the Adoption of Digital Pathology in the U.K.
                        10.3.1.2 Technological Developments in the U.K. Market
                        10.3.1.3 Organization of Digital Pathology-Related Conferences in the U.K.
                        10.3.1.4 Organization of Digital Pathology-Related Conferences in Germany
                        10.3.1.5 Successful Digital Pathology Projects in Italy
                        10.3.1.6 Active Involvement of Industry Players to Augment the Demand for Digital Pathology in France
                        10.3.1.7 Implementation of Digital Pathology-Related Projects to Drive Market Growth in Spain
             10.3.2 RoE
                        10.3.2.1 High Cancer Prevalence to Boost Market Growth in Denmark
                        10.3.2.2 Norway: Conferences and Industry Collaborations in the Regional Market
                        10.3.2.3 Increased Investments By Government Bodies in Sweden
                        10.3.2.4 Digital Pathology Gaining Momentum in the Netherlands
     10.4 Asia-Pacific
             10.4.1 China
                        10.4.1.1 Industry Initiatives to Boost Digital Pathology Market in China
                        10.4.1.2 Favorable Initiatives for the Adoption of Telepathology in China
             10.4.2 Japan
                        10.4.2.1 Initiatives By Nec for Cancer Diagnosis to Propel the Market in Japan
             10.4.3 India
                        10.4.3.1 Focus of Market Players on India
             10.4.4 RoAPAC
                        10.4.4.1 Cancer Control Initiatives in Australia
                        10.4.4.2 Approvals for Digital Pathology Solutions in South Korea, Partnerships Between Local and Global Players
     10.5 RoW
             10.5.1 Potential for the Growth of Digital Pathology in Africa
             10.5.2 Increasing Focus By Industry Players and Academic Institutes on the Brazilian Market
             10.5.3 Increasing Focus of Industry Players on Organic Growth Strategies in the Middle East

11 Competitive Landscape (Page No. - 105)
     11.1 Overview
     11.2 Competitive Situation and Trends
             11.2.1 Agreements, Collaborations, and Partnerships
             11.2.2 Product Launches
             11.2.3 Client Acquisitions
             11.2.4 Expansions
             11.2.5 Acquisitions
             11.2.6 Other Strategies

12 Company Profiles (Page No. - 116)
(Overview, Financial*, Products & Services, Strategy, and Developments)
     12.1 Introduction
     12.2 Leica Biosystems Nussloch GMBH (Subsidiary of Danaher Corp)
     12.3 Ventana Medical Systems, Inc. (Member of Roche Group)
     12.4 Hamamatsu Photonics K.K.
     12.5 3dhistech Ltd.
     12.6 Philips Healthcare
     12.7 Apollo Enterprise Imaging Corp. (Formerly Apollo Pacs, Inc.)
     12.8 Xifin, Inc.
     12.9 Definiens AG
     12.10 Visiopharm A/S
     12.11 Omnyx, LLC (Venture By Ge Healthcare and UPMC)
     12.12 Corista LLC

*Details Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 141)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Company Developments (2013–2016)
             13.3.1 Leica Biosystems Nussloch GMBH (A Subsidiary of Danaher Corp)
             13.3.2 Ventana Medical Systems, Inc. (A Member of Roche Group)
             13.3.3 Philips Healthcare
             13.3.4 Apollo Enterprise Imaging Corp. (Formerly Apollo Pacs, Inc.)
             13.3.5 Definiens AG
             13.3.6 Visiopharm A/S
             13.3.7 Omnyx, LLC (A Venture By Ge Healthcare and UPMC)
     13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.5 Introducing RT: Real-Time Market Intelligence
     13.6 Available Customizations
     13.7 Related Reports


List of Tables (78 Tables)

Table 1 Global Digital Pathology Market Size, By Product, 2014–2021 (USD Million)
Table 2 Digital Pathology Scanners Market Size, By Country/Region, 2014–2021 (USD Million)
Table 3 Digital Pathology Scanners Volume Sold, By Region, 2014–2021
Table 4 Types of Digital Pathology Software
Table 5 Digital Pathology Software Market Size, By Country/Region, 2014–2021 (USD Million)
Table 6 Communication Systems Used in Digital Pathology
Table 7 Digital Pathology Communication Systems Market Size, By Country/Region, 2014–2021 (USD Million)
Table 8 Digital Pathology Storage Systems Market Size, By Country/Region, 2014–2021 (USD Million)
Table 9 Global Market Size, By Type, 2014–2021 (USD Million)
Table 10 Human Market Size, By Country/Region, 2014–2021 (USD Million)
Table 11 Animal Market Size, By Country/ Region, 2014–2021 (USD Million)
Table 12 Global Market Size, By End User, 2014–2021 (USD Million)
Table 13 Global Market Size for Pharmaceutical and Biotechnology Companies & Cros, By Country/Region, 2014–2021 (USD Million)
Table 14 Global Market Size for Hospitals and Reference Laboratories, By Country/Region, 2014–2021 (USD Million)
Table 15 Global Market Size for Academic & Government Research Institutes, By Country/Region, 2014–2021 (USD Million)
Table 16 Global Market Size, By Application, 2014–2021 (USD Million)
Table 17 Global Market Size for Teleconsultation, By Region/Country, 2014–2021 (USD Million)
Table 18 Global Market Size for Disease Diagnosis, By Country/Region, 2014–2021 (USD Million)
Table 19 Global Market Size for Drug Discovery, By Country/Region, 2014–2021 (USD Million)
Table 20 Global Market Size for Training and Education, By Country/Region, 2014–2021 (USD Million)
Table 21 Market Size, By Region, 2014–2021 (USD Million)
Table 22 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 23 North America: Market Size, By Product, 2014–2021 (USD Million)
Table 24 North America: Market Size, By Type, 2014–2021 (USD Million)
Table 25 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 26 North America: Market Size, By Application, 2014–2021 (USD Million)
Table 27 U.S.: Market Size, By Product, 2014–2021 (USD Million)
Table 28 U.S.: Market Size, By Type, 2014–2021 (USD Million)
Table 29 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 30 U.S.: Market Size, By Application, 2014–2021 (USD Million)
Table 31 Canada: Market Size, By Product, 2014–2021 (USD Million)
Table 32 Canada: Market Size, By Type, 2014–2021 (USD Million)
Table 33 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 34 Canada: Market Size, By Application, 2014–2021 (USD Million)
Table 35 Europe: Market Size, By Region, 2014–2021 (USD Million)
Table 36 Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 37 Europe: Market Size, By Type, 2014–2021 (USD Million)
Table 38 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 39 Europe: Market Size, By Application, 2014–2021 (USD Million)
Table 40 EU-5: Market Size, By Product, 2014–2021 (USD Million)
Table 41 EU-5: Market Size, By Type, 2014–2021 (USD Million)
Table 42 EU-5: Market Size, By End User, 2014–2021 (USD Million)
Table 43 EU-5: Market Size, By Application, 2014–2021 (USD Million)
Table 44 RoE: Market Size, By Product, 2014–2021 (USD Million)
Table 45 RoE: Market Size, By Type, 2014–2021 (USD Million)
Table 46 RoE: Market Size, By End User, 2014–2021 (USD Million)
Table 47 RoE: Market Size, By Application, 2014–2021 (USD Million)
Table 48 Asia-Pacific: Market Size, By Region, 2014–2021 (USD Million)
Table 49 Asia-Pacific: Market Size, By Product, 2014–2021 (USD Million)
Table 50 Asia-Pacific: Market Size, By Type, 2014–2021 (USD Million)
Table 51 Asia-Pacific: Market Size, By End User, 2014–2021 (USD Million)
Table 52 Asia-Pacific: Market Size, By Application, 2014–2021 (USD Million)
Table 53 China: Market Size, By Product, 2014–2021 (USD Million)
Table 54 China: Market Size, By Type, 2014–2021 (USD Million)
Table 55 China: Market Size, By End User, 2014–2021 (USD Million)
Table 56 China: Market Size, By Application, 2014–2021 (USD Million)
Table 57 Japan: Market Size, By Product, 2014–2021 (USD Million)
Table 58 Japan: Market Size, By Type, 2014–2021 (USD Million)
Table 59 Japan: Market Size, By End User, 2014–2021 (USD Million)
Table 60 Japan: Market Size, By Application, 2014–2021 (USD Million)
Table 61 India: Market Size, By Product, 2014–2021 (USD Million)
Table 62 India: Market Size, By Type, 2014–2021 (USD Million)
Table 63 India: Market Size, By End User, 2014–2021 (USD Million)
Table 64 India: Market Size, By Application, 2014–2021 (USD Million)
Table 65 RoAPAC: Market Size, By Product, 2014–2021 (USD Million)
Table 66 RoAPAC: Market Size, By Type, 2014–2021 (USD Million)
Table 67 RoAPAC: Market Size, By End User, 2014–2021 (USD Million)
Table 68 RoAPAC: Market Size, By Application, 2014–2021 (USD Million)
Table 69 RoW: Market Size, By Product, 2014–2021 (USD Million)
Table 70 RoW: Market Size, By Type, 2014–2021 (USD Million)
Table 71 RoW: Market Size, By End User, 2014–2021 (USD Million)
Table 72 RoW: Market Size, By Application, 2014–2021 (USD Million)
Table 73 Recent Developments, 2013–2016
Table 74 Recent Developments, 2013–2016
Table 75 Recent Developments, 2013–2016
Table 76 Recent Developments, 2013–2016
Table 77 Recent Developments, 2013–2016
Table 78 Recent Developments, 2013–2016


List of Figures (41 Figures)

Figure 1 Global Digital Pathology Market Segmentation
Figure 2 Global Digital Pathology Market: Research Methodology Steps
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Global Market Analysis, By Product (2016)
Figure 8 Global Market Analysis, By Type, 2016 vs 2021
Figure 9 Global Market Analysis, By End User, 2016 vs 2021
Figure 10 Global Market Analysis, By Application (2016)
Figure 11 Asia-Pacific Market to Witness Highest Growth During the Forecast Period
Figure 12 Attractive Opportunities in the Market
Figure 13 North America to Dominate the Market
Figure 14 Human Pathology Segment to Grow at the Highest Rate
Figure 15 Pharmaceutical & Biotechnology Companies and Cros Segment to Witness Highest Growth During the Forecast Period
Figure 16 Teleconsultation Segment Will Command the Largest Share of the Digital Pathology Market in 2021
Figure 17 Asia-Pacific to Register Highest Growth Rate From 2016 to 2021
Figure 18 Global Digital Pathology Market Segmentation
Figure 19 Drivers, Restraints, and Opportunities
Figure 20 Digital Pathology Market Segmentation, By Product
Figure 21 Global Market, By Type, 2016–2021
Figure 22 Digital Pathology Market Segmentation, By End User
Figure 23 Teleconsultation to Command Largest Share of the Digital Pathology Market, By Application
Figure 24 Digital Pathology Market, By Region, 2016
Figure 25 North America: Digital Pathology Market Snapshot
Figure 26 Europe: Digital Pathology Market Snapshot
Figure 27 Asia-Pacific Digital Pathology Market Snapshot
Figure 28 RoW Digital Pathology Market Snapshot
Figure 29 Figure: Growth Strategies, By Company
Figure 30 Acquisitions & Expansions Were the Key Growth Strategies Adopted By Market Players
Figure 31 Agreements, Collaborations, and Partnerships, By Company (2013–2016)
Figure 32 Product Launches, By Company (2013–2016)
Figure 33 Client Acquisitions, By Company (2013–2016)
Figure 34 Expansions, By Company (2013–2016)
Figure 35 Acquisitions, By Company (2013–2016)
Figure 36 Other Strategies, By Company (2013–2016)
Figure 37 Products and Services Offered By Companies
Figure 38 Danaher Corporation: Company Snapshot
Figure 39 Roche Group: Company Snapshot
Figure 40 Hamamatsu Photonics K.K.: Company Snapshot
Figure 41 Philips Healthcare: Company Snapshot

The global digital pathology market is expected to reach USD 679.1 Million by 2021 from USD 384.3 Million in 2016, growing at a CAGR of 12.1% from 2016 to 2021.

The global digital pathology market is segmented on the basis of product, type, end-users and application. By product, the market is segmented into scanners, software, communication system and storage systems. The scanners segment is estimated to account for the largest share of the global market in 2016. Software segment is projected to grow at the highest CAGR during the forecast period. This growth is attributed to the availability of user-friendly, analytical and advanced software’s for pathology diagnosis.

On basis of type, the market is segmented into human and animal pathology. The human pathology segment is expected to account for the largest share of the market in 2016. This is attributed to the increasing utilization of digital pathology for chronic disease diagnosis and rising technological developments in human pathology diagnostics across the globe.

On the basis of end users, the digital pathology market is segmented into pharmaceutical and biotechnology companies and contract research organizations (CROs); hospitals and reference laboratories; and academic and government agencies. The pharmaceutical and biotechnology companies and CROs segment is expected to account for the largest share of the market in 2016, and is projected to grow at the highest CAGR during the forecast period. Growing need to curtail escalating costs in drug discovery research and increase in the operational efficiencies of pharmaceutical companies using digital pathology attributed to the growth of this market.

The digital pathology market, based on application, is segmented into disease diagnosis; teleconsultation; drug discovery; and education & training. The teleconsultation segment is expected to account for the largest share of the market in 2016. This is mainly attributed to shortage of pathologists and increasing need for quality and fast pathology diagnosis using remote consultation in developing countries. This segment is expected to grow at the highest CAGR during the forecast period.

On the basis of regions, the digital pathology market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market in 2016. The large share of the North American region can be attributed to the rising chronic disease prevalence and increasing initiatives by industry players and government in field of diagnostics. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period.

Digital Pathology Market

Source: Digital Pathology Association (DPA), the College of American Pathologists (CAP), American Society for Clinical Pathology, U.S. Department of Health and Human Services, Canadian Association of Pathologists, European Society of Pathology, Pathological Society of Great Britain and Ireland, International Academy of Pathology, World Health Organization (WHO), the International Association of Chinese Pathologists, Annual Reports, Press Releases, Expert Interviews, and MarketsandMarkets Analysis

Some of the major players in the digital pathology market are Leica Biosystems Nussloch GMBH (Germany), Ventana Medical Systems, Inc.(U.S.), Hamamatsu Photonics K.K (Japan), 3D Histech Ltd(Hungary)., Philips Healthcare (Netherlands), Apollo Enterprise Imaging Corp.(U.S.), Xifin, Inc. (U.S.), Definiens AG (Germany), Visiopharm A/S (Denmark), Omnyx, LLC.(U.S.), Corista LLC (U.S.).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Healthcare IT Markets on KnowledgeStore
Request Demo